Biochemical and Histopathological Investigation of Resveratrol, Gliclazide, and Losartan Protective Effects on Renal Damage in a Diabetic Rat Model

Ezel, TasdemirKocyigit, YukselDeveci, EnginAtamer, YildizSermet, AbdurrahmanUysal, ErsinAktas, Ayfer2024-04-242024-04-2420150884-6812https://hdl.handle.net/11468/22817[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessAngiogenesis InhibitorsAntihypertensive AgentsDiabetes ComplicationsDiabetes InsipidusNephrogenicDiabetes MellitusDiabetic Kidney DiseaseDiabetic NephropathyGliclazideHypoglycemic AgentsLosartanResveratrolBiochemical and Histopathological Investigation of Resveratrol, Gliclazide, and Losartan Protective Effects on Renal Damage in a Diabetic Rat ModelBiochemical and Histopathological Investigation of Resveratrol, Gliclazide, and Losartan Protective Effects on Renal Damage in a Diabetic Rat ModelArticle373187198WOS:00035699020000626173356Q4